Skip to main content
SpringerLink
Log in

Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: To investigate the potential contribution of immune-mediated processes to the development of proliferative diabetic retinopathy (PDR), an immunohistochemical study was undertaken to characterize the infiltrating immune cells in epiretinal membranes from the eyes of patients with PDR. • Methods: A total of 18 PDR epiretinal membrane specimens obtained surgically from pars plana vitrectomy were studied by using a panel of monoclonal antibodies against T lymphocytes (CD4 and CD8), interleukin-2 (IL-2) and interleukin-2 receptors (IL-2R). • Results: Twelve of 18 specimens (67%) contained CD4-positive cells and 13 of 18 (73%) contained CD8-positive cells. IL-2 was found in 12 of 18 samples (67%), of which 11 also contained CD4-positive cells, and IL-2R was detected in 10 of 18 membranes (56%), of which 9 contained CD4-positive cells and released IL-2. Most of the IL-2R-positive membranes were from type I diabetic patients, 40% of them from patients younger than 40 years. • Conclusion: Our study demonstrated the involvement of activated immune cells and release of lymphokine(s) in more than half of the diabetic epiretinal membranes tested and revealed that the processes of immune responses and the biological effects of lymphokine(s) may play an important part in the development of epiretinal membranes of PDR, especially in young-onset and type I diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abu El Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731–736

    PubMed  Google Scholar 

  2. Aharonov O, Maftzir G, BenEzra D (1993) The role of cytokines in angiogenesis. Ocular Immunol Inflam 1:135–141

    Google Scholar 

  3. Auerbach R, Kubai L, Sidky YA (1976) Angiogenesis induction by tumors, embryonic tissues, and lymphocytes. Cancer Res 36:3435–3440

    Google Scholar 

  4. Auerbach R, Sidky YA (1979) Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol 123:751–754

    Google Scholar 

  5. Barbul A (1988) Role of T cell-dependent immune system in wound healing. Prog Clin Biol Res 266:161–175

    Google Scholar 

  6. Baudouin C, Fredj-Reygrobellet D, Lapalus P, Gastaud P (1988) Immunohistopathological findings in proliferative diabetic retinopathy. Am J Ophthalmol 105:383–388

    Google Scholar 

  7. Baudouin C, Gordon WC, Fredj-Reygrobellet D, Baudouin F, Peyman G, Gastaud P, Bazan NC (1990) Class II antigen expression in diabetic preretinal membranes. Am J Ophthalmol 109:70–74

    Google Scholar 

  8. Beutler B, Cerami A (1986) Cachectin and tumor necrosis factor as two sides of the biological coin. Nature 320:584–588

    Google Scholar 

  9. Charteris DG, Hiscott P, Grierson I, Lightman SL (1992) Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 99:1364–1367

    Google Scholar 

  10. Connor TB, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M, Hayashi H, Glaser BM (1989) Correlations of fibrosis and transforming growth factor-β type 2 level in eye. J Clin Invest 83:1661–1666

    Google Scholar 

  11. Cordell JL, Falini B, Erber NW, Ghosh AK, Abdulaziz Z, McDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229

    CAS  PubMed  Google Scholar 

  12. Donnelly JJ, Li W, Rockey JH, Prendergast RA (1985) Induction of class II (Ia) alloantigen expression on corneal endothelium in vivo and in vitro. Invest Ophthalmol Vis Sci 26:575–580

    Google Scholar 

  13. Farrar JJ, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J (1982) The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev 63:129–166

    Google Scholar 

  14. Hamel CP, Detrick B, Hooks JJ (1990) Evaluation of la expression in rat ocular tissues following inoculation with interferon-gamma. Exp Eye Res 50:173–182

    Google Scholar 

  15. Hooks JJ, Chan CC, Detrick B (1988) Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci 29:1444–1451

    Google Scholar 

  16. Howard M, Matis L, Malek TR, Shevach R, Kell W, Cohen D, Nakanishi K, Paul WE (1983) Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-1. J Exp Med 158:2024–2039

    Google Scholar 

  17. Husby G, Williams RC (1985) Immunohistochemical studies of interleukin 2 and interferon-gamma in rheumatoid arthritis. Arthritis Rheum 28:17–25

    Google Scholar 

  18. Isenberg DA, Rowe D, Shearer M, Novick D, Beverley PCL (1986) Localization of interferons and interleukin-2 in polymyositis and muscular dystrophy. Clin Exp Immunol 63:450–458

    Google Scholar 

  19. Jerdan JA, Michels RG, Glaser BM (1986) Diabetic preretinal membranes. An immunohistochemical study. Arch Ophthalmol 104:286–290]

    Google Scholar 

  20. Jiang LQ, Streilein JW (1990) Immune privilege in the murine vitreous cavity. Invest Ophthalmol Vis Sci 31 [Suppl]:31

    Google Scholar 

  21. Kuziel WA, Greene WC (1991) Interleukin-2. In: Thomson AW (ed) The cytokine handbook. Academic Press, London, pp 83–102

    Google Scholar 

  22. Lutty GA, Liu SH, Prendergast RA (1983) Angiogenic lymphokines of activated T-cell origin. Invest Ophthalmol Vis Sci 24:1595–1601

    Google Scholar 

  23. Maftzir G, Aharonov O, BenEzra D (1992) Influence of interferons on corneal angiogenesis induced by basic fibroblast growth factor and lipopolysaccharide. Ocular Immunol Inflam 1:143–150

    Google Scholar 

  24. Melato M, Antonoto JG, Mangoni R, Poute E (1982) Ocular deposits of immunoglobulin in diabetic retinopathy. Can J Ophthalmol 17:45–46

    Google Scholar 

  25. Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007–1008

    Google Scholar 

  26. Moses HL, Tucker RF, Leof EB, Coffey RJ, Halper J, Shipley GD (1985) Type-β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells 3:65–71

    Google Scholar 

  27. Oppenheim JJ, Kovacs EJ, Matushima K, Durum SK (1986) There is more than one interleukin 1. Immunol Today 7:45–56

    Google Scholar 

  28. Perussia B, Mangoni L, Engers HD, Trinchieri G (1980) Interferon production by human and murine lymphocytes in response to alloantigens. J Immunol 125:1589–1595

    Google Scholar 

  29. Piguet PF, Collart MA, Gran GE, Kapanci Y, Vassalli P (1989) Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy in fibrosis. J Exp Med 170:655–663

    Google Scholar 

  30. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type-B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171

    Google Scholar 

  31. Roehm NW, Sidky YA, Auerbach R (1981) Lyt phenotype analysis of the effector cells responsible for evoking lymphocyte-induced angiogenesis (LIA). Cell Immunol 63:272–278

    Google Scholar 

  32. Scheiffarth OF, Tang S, Kampik A (1990) Makrophagen und HLA-DR Antigen Expression bei prolierativer Vitreoretinopathie. Fortschr Ophthalmol 87:340:343

    Google Scholar 

  33. Sidky YA, Auerbach R (1975) Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med 141:1084–1100

    Google Scholar 

  34. Tang S, Le-Ruppert KC (1993) Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranes. Invest Ophthalmol Vis Sci 34 [Suppl]:1206

    Google Scholar 

  35. Tang S, Scheiffarth OF, Wildner G, Thurau SR (1992) Cells of the immune system in epiretinal membranes of patients with proliferative diabetic retinopathy (PDR). Invest Ophthalmol Vis Sci 33 [Suppl]:857

    Google Scholar 

  36. Tang S, Scheiffarth OF, Thurau SR, Wildner G (1993) Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic Res 25:177–185

    Google Scholar 

  37. Trinchieri G, Perussia B (1985) Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 6:131–136

    Google Scholar 

  38. Whal SM, Allen JB (1988) T lymphocyte-dependent mechanisms of fibrosis. Prog Clin Biol Res 266:147–160

    Google Scholar 

  39. Wiedemann P (1992) Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373–384

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Eye Hospital Regensburg, Franz-Josef-Strauss-Allee 11, D-93053, Regensburg, Germany

    Shibo Tang & Kim Chi Le-Ruppert

Authors
  1. Shibo Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim Chi Le-Ruppert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, S., Le-Ruppert, K.C. Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol 233, 21–25 (1995). https://doi.org/10.1007/BF00177781

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177781

Keywords

Search

Navigation